Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filedfiledCritical
Priority claimed from PCT/EP2010/067250external-prioritypatent/WO2011058083A1/en
Publication of UA109420C2publicationCriticalpatent/UA109420C2/en
Винахід стосується рідкої композиції, що включає агоніст GLP-1 (desProексендин-4(1-39)-LyS-NH) і/або його фармакологічно прийнятну сіль, інсулін (Gly(A21)-Arg(B31)-Arg(B32)-iнcyлiн людини) і/або його фармакологічно прийнятну сіль і, необов'язково, щонайменше одну фармацевтично прийнятну допоміжну речовину, де дана композиція містить L-метіонін та має значення pH від 3,5 до 4,5.The invention relates to a liquid composition comprising the GLP-1 agonist (desProexendin-4 (1-39) -LyS-NH) and / or its pharmacologically acceptable salt, insulin (Gly (A21) -Arg (B31) -Arg (B32) - human incyline) and / or its pharmacologically acceptable salt and, optionally, at least one pharmaceutically acceptable excipient, wherein the composition contains L-methionine and has a pH of from 3.5 to 4.5.
UAA201207165A2009-11-132010-11-11
PHARMACEUTICAL COMPOSITION INCLUDING GLP-1 AGONIST, INSULIN AND METHIONINE
UA109420C2
(en)
COMPOSITE OF (METHANOSULPHONYL -PIPERIDIN) - (ALCOXI-ARIL) -TETRAHIDRO- PYRIDINE, PHARMACEUTICAL COMPOSITION THAT INCLUDES IT AND ITS USE TO PREPARE A USEFUL MEDICINAL PRODUCT FOR THE TREATMENT OF DIABETES OR OBESITY
Glucagon analog, gip and glp-1 agonist; dimer comprising the glucagon analog; conjugated to the analog; composition comprising said analog; use to prepare a medicine to treat diabetes, reduce weight gain, or induce weight loss.
COMPOUNDS DERIVED FROM AZACICLOALCANOS, INHIBITORS FROM ESTEAROIL-COENZIMA TO DELTA-9 DESATURASA; PHARMACEUTICAL COMPOSITION; AND USE FOR THE TREATMENT OF DISEASES SUCH AS TYPE 2 DIABETES, INSULIN RESISTANCE, LIPID DISORDERS, OBESIDA
COMPOUNDS DERIVED FROM PIRIMIDINONE CONDENSED WITH HETEROCICLES; PHARMACEUTICAL COMPOSITION; AND USE IN THE TREATMENT OF DISEASES SUCH AS DIABETES, METABOLIC SYNDROME AND OBESITY.
COMPOUNDS DERIVED FROM PIRIMIDINONE CONDENSED WITH HETEROCICLES; PHARMACEUTICAL COMPOSITION; AND USE IN THE TREATMENT OF DISEASES SUCH AS DIABETES, METABOLIC SYNDROME AND OBESITY.
COMPOUNDS DERIVED FROM IMIDAZOLINE-2,4-DION SUBSTITUTED WITH ARILAMINOALQUILO; PHARMACEUTICAL COMPOSITION; AND USE OF THE COMPOUND IN THE TREATMENT OF METABOLIC SYNDROME, DIABETES, OBESITY, NICOTINE DEPENDENCE, ALCOHOL DEPENDENCE, DISORDER
PEPTIDES AND PEPTIDE DERIVATIVES, THEIR PRODUCTION AND THEIR USE FOR PRODUCING A THERAPEUTIC AND/OR PROPHYLACTICALLY EFFECTIVE PHARMACEUTICAL COMPOSITION
AMIDA COMPOUND OF THE CYCLOPROPANOCARBOXYL ACID, PHARMACEUTICAL COMPOSITION THAT INCLUDES IT AND USE TO PREPARE A USEFUL MEDICINAL PRODUCT FOR THE TREATMENT OF DIABETES